Human Genes as Company Property Tested by Myriad Patent Case

As scientists successfully decode and isolate human DNA in the race for new drugs, the ability to protect and profit from what they find has yet to be mapped.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.